10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
ABBOTT LABORATORIES | ||
Ticker: ABT Fiscal Year: 2017 | ||
Consolidated Balance Sheet | ||
Period Ending Dec 31, 2017 10-K (Filed: Feb 16, 2018) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2017 | Dec 31, 2016 | |
| Assets | ||
| Current Assets: | ||
| Cash and cash equivalents | $ 9,407 | 18,620 |
| Investments, primarily bank time deposits and U.S. treasury bills | 203 | 155 |
| Trade receivables, less allowances of - 2017: $294; 2016: $250 | 5,249 | 3,248 |
| Inventories: | ||
| Finished products | 2,339 | 1,624 |
| Work in process | 472 | 294 |
| Materials | 790 | 516 |
| Total inventories | 3,601 | 2,434 |
| Other prepaid expenses and receivables | 1,667 | 1,806 |
| Current assets held for disposition | 20 | 513 |
| Total Current Assets | 20,147 | 26,776 |
| Investments | 883 | 2,947 |
| Property and Equipment, at Cost: | ||
| Land | 526 | 408 |
| Buildings | 3,613 | 2,602 |
| Equipment | 10,394 | 8,394 |
| Construction in progress | 732 | 962 |
| Property and Equipment, at cost | 15,265 | 12,366 |
| Less: accumulated depreciation and amortization | 7,658 | 6,661 |
| Net Property and Equipment | 7,607 | 5,705 |
| Intangible Assets, net of amortization | 21,473 | 4,539 |
| Goodwill | 24,020 | 7,683 |
| Deferred Income Taxes and Other Assets | 1,944 | 2,263 |
| Non-current Assets Held for Disposition | 176 | 2,753 |
| Total Assets | 76,250 | 52,666 |
| Liabilities and Shareholders' Investment | ||
| Current Liabilities: | ||
| Short-term borrowings | 206 | 1,322 |
| Trade accounts payable | 2,402 | 1,178 |
| Salaries, wages and commissions | 1,187 | 752 |
| Other accrued liabilities | 3,811 | 2,581 |
| Dividends payable | 489 | 391 |
| Income taxes payable | 309 | 188 |
| Current portion of long-term debt | 508 | 3 |
| Current liabilities held for disposition | 245 | |
| Total Current Liabilities | 8,912 | 6,660 |
| Long-term debt | 27,210 | 20,681 |
| Post-employment obligations and other long-term liabilities | 9,030 | 4,549 |
| Non-current liabilities held for disposition | 59 | |
| Commitments and Contingencies | ||
| Shareholders' Investment: | ||
| Preferred shares, one dollar par value Authorized - 1,000,000 shares, none issued | ||
| Common shares, without par value Authorized - 2,400,000,000 shares Issued at stated capital amount - Shares: 2017: 1,965,908,188; 2016: 1,707,475,455 | 23,206 | 13,027 |
| Common shares held in treasury, at cost - Shares: 2017: 222,305,719; 2016: 234,606,250 | (10,225) | (10,791) |
| Earnings employed in the business | 23,978 | 25,565 |
| Accumulated other comprehensive income (loss) | (6,062) | (7,263) |
| Total Abbott Shareholders' Investment | 30,897 | 20,538 |
| Noncontrolling Interests in Subsidiaries | 201 | 179 |
| Total Shareholders' Investment | 31,098 | 20,717 |
| Total Liabilities and Shareholders' Investment | 76,250 | 52,666 |
| External Links | |
| ABBOTT LABORATORIES (ABT) Fiscal Year 2017 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |